RAC 2.20% $1.78 race oncology ltd

Ann: A$3m strategic investment from prominent biotech investors, page-15

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29637
    Agree, extraordinarily positive. We can expect investors that follow smart money to start buying.

    By my calculations 4.27% on issued shares and 3.26% on a fully-diluted basis.

    This will lift fully-diluted shares to ~ 158.6M (note that all my valuations use 200M fully-diluted ).

    By July to August 2021 we should see another $3.2M of funds from exercising of options.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.